[go: up one dir, main page]

AU2003300655A1 - Human variants of kallikrein-2 and kallikrein-3 and uses thereof - Google Patents

Human variants of kallikrein-2 and kallikrein-3 and uses thereof

Info

Publication number
AU2003300655A1
AU2003300655A1 AU2003300655A AU2003300655A AU2003300655A1 AU 2003300655 A1 AU2003300655 A1 AU 2003300655A1 AU 2003300655 A AU2003300655 A AU 2003300655A AU 2003300655 A AU2003300655 A AU 2003300655A AU 2003300655 A1 AU2003300655 A1 AU 2003300655A1
Authority
AU
Australia
Prior art keywords
kallikrein
human variants
variants
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003300655A
Other versions
AU2003300655A8 (en
Inventor
Laurent Bracco
Brigitta Brinkman
Fanny Coignard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ExonHit Therapeutics SA
Original Assignee
ExonHit Therapeutics SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ExonHit Therapeutics SA filed Critical ExonHit Therapeutics SA
Publication of AU2003300655A1 publication Critical patent/AU2003300655A1/en
Publication of AU2003300655A8 publication Critical patent/AU2003300655A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6445—Kallikreins (3.4.21.34; 3.4.21.35)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003300655A 2002-12-17 2003-12-17 Human variants of kallikrein-2 and kallikrein-3 and uses thereof Abandoned AU2003300655A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR02/16019 2002-12-17
FR0216019A FR2848569A1 (en) 2002-12-17 2002-12-17 New nucleic acid encoding variants of human kallikrein-3, useful for diagnosis of prostatic cancer and in screening for therapeutic agents, also related polypeptides and antibodies
PCT/FR2003/003775 WO2004056989A2 (en) 2002-12-17 2003-12-17 Human variants of kallikrein-2 and kallikrein-3 and uses thereof

Publications (2)

Publication Number Publication Date
AU2003300655A1 true AU2003300655A1 (en) 2004-07-14
AU2003300655A8 AU2003300655A8 (en) 2004-07-14

Family

ID=32338902

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003300655A Abandoned AU2003300655A1 (en) 2002-12-17 2003-12-17 Human variants of kallikrein-2 and kallikrein-3 and uses thereof

Country Status (3)

Country Link
AU (1) AU2003300655A1 (en)
FR (1) FR2848569A1 (en)
WO (1) WO2004056989A2 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2775984B1 (en) * 1998-03-11 2006-09-15 Bioscreen Therapeutics Sa QUALITATIVE DIFFERENTIAL SCREENING
CA2340616A1 (en) * 1998-08-24 2000-03-02 Alphagene, Inc. Secreted proteins and polynucleotides encoding them
WO2000049158A2 (en) * 1999-02-18 2000-08-24 Compugen Ltd. Psa and klk-2 splicing variants
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
WO2002074961A1 (en) * 2001-03-15 2002-09-26 Hyseq, Inc. Novel nucleic acids and polypeptides
CA2478572A1 (en) * 2002-03-14 2003-09-18 Fanny Coignard Variants of human kallikrein-2 and kallikrein-3 and uses thereof

Also Published As

Publication number Publication date
FR2848569A1 (en) 2004-06-18
WO2004056989A3 (en) 2005-01-06
AU2003300655A8 (en) 2004-07-14
WO2004056989A2 (en) 2004-07-08

Similar Documents

Publication Publication Date Title
AU2003290548A1 (en) Prevention and treatment of synucleinopathic disease
AU2003288902A1 (en) Microcapsules and methods of use
AU2001286171A1 (en) Human cDNAs and proteins and uses thereof
AU2003239957A1 (en) Optically-connected implants and related systems and methods of use
AU2003275311A1 (en) Solid micro-perforators and methods of use
AU2003216363A1 (en) Massager and method of using same
AU2002314466A1 (en) Withasol and methods of use
AU2002335085A1 (en) Angiopoietins and methods of use thereof
AU2002323210A1 (en) Bio-synthetic photostimulators and methods of use
AU2003300323A1 (en) Vascular prosthesis and methods of use
EP1581147A3 (en) Vascular prosthesis and methods of use
AU2002315166A1 (en) Sir2alpha-based therapeutic and prophylactic methods
AU2002359512A1 (en) Belts and methods of use thereof
AU2003259717A1 (en) Modulators of rabggt and methods of use thereof
AU2003295343A1 (en) Uses of human zven proteins and polynucleotides
AU2003225161A1 (en) Enhancement of human epidermal melanogenesis
AU2003245487A1 (en) Cosmetic appliance and method of use
AU2002363938A1 (en) Methods and use of motoneuronotropic factors
AU2003287802A1 (en) Palpometer and methods of use thereof
AU2002246950A1 (en) Hydrocapsules and method of preparation
AU2003213898A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2003285686A1 (en) Glycoisoforms of adiponectin and uses thereof
AU2003261900A1 (en) Method of designing physiologically active peptide and use thereof
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2003274919A1 (en) Multifunctional context-activated protides and methods of use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase